Scientists at the University of Virginia have uncovered a major clue that may help explain why men, on average, live shorter lives than women. The study, led by researcher Kenneth Walsh, found that as men age, they often lose the Y chromosome from some of their blood cells—and this loss may have serious health consequences, especially for the heart.
By the age of 70, about 40% of men have lost the Y chromosome in at least some of their white blood cells. This condition, known as mosaic loss of the Y chromosome, has long been observed in aging men, but until now, its direct effects on health were not fully understood.
Walsh and his team discovered that the loss of the Y chromosome is strongly linked to scarring in heart muscle, also known as fibrosis. This scarring can weaken the heart over time and eventually lead to heart failure, a potentially fatal condition.
The researchers believe this may be one of the reasons why men tend to die around five years earlier than women. Their data suggests that Y chromosome loss could explain up to four years of that gap.
To study this further, the researchers used CRISPR, a powerful gene-editing tool, to create a special mouse model that mimicked the Y chromosome loss seen in aging men. These mice experienced faster aging, more heart scarring, and shorter lifespans compared to normal mice.
Importantly, the damage wasn’t just caused by general inflammation—it appeared to be due to complex changes in the immune system that led to widespread fibrosis.
The Y chromosome has often been thought of as relatively unimportant because it contains fewer genes than other chromosomes. However, this study proves it plays a crucial role in maintaining health, especially as men grow older.
This isn’t the first time Y chromosome loss has been connected to health problems. In the past, it has been associated with a higher risk of Alzheimer’s disease and some types of cancer. But this is the first solid evidence linking it to direct damage in the heart and shortened lifespan.
The research also points to potential treatments. One promising drug is pirfenidone, which is already approved by the FDA to treat a lung condition called idiopathic pulmonary fibrosis, where lung tissue becomes scarred. Because this drug reduces fibrosis, scientists are now testing whether it might also help reduce heart scarring caused by Y chromosome loss.
If successful, treatments like pirfenidone could help extend the healthy lifespans of men, especially those at risk of heart failure or other scarring-related diseases. This could be a game-changer in men’s health, offering new hope for fighting age-related disease by addressing a previously overlooked factor.
Overall, this groundbreaking study opens the door to new research and therapies aimed at slowing aging and improving the health of men as they grow older. It’s a reminder that even small changes in our DNA can have a big impact on how long—and how well—we live.
If you care about wellness, please read studies about nutrients that could combat inflammation in older people, and essential foods for healthy aging.
For more health information, please see recent studies about the link between processed foods and chronic diseases, and a simple diet change for a healthier life after 65.
Copyright © 2025 Knowridge Science Report. All rights reserved.
